.Sanofi has actually made an overdue entry to the radioligand event, paying out 100 thousand euros (...
.After F2G's 1st try to get a brand-new lesson of antifungal to market was actually wrecked by the F...
.Moderna has actually pledged to cut R&D costs by $1.1 billion by 2027. The choice to retract the...
.Just 4 months after Sanofi bet $80 thousand in upfront money on Fulcrum Therapeutics' losmapimod, t...
.Cancer cells provider Oncternal Rehabs is folding all its professional tests and laying off workers...
.Roche is actually storing out hopes that its injectable weight problems prospect might inevitably d...
.Novo Nordisk has elevated the cover on a stage 1 trial of its own oral amylin as well as GLP-1 rece...
.Merely a couple of brief full weeks after gaining an FDA Fast Track tag for its own investigational...
.Soon after a positive information drop for Eli Lilly's efsitora alfa, the Indianapolis-based firm i...
.BridgeBio Pharma is lowering its genetics treatment budget and pulling back from the method after s...